- Rank in Search Criteria: 5591
World Rank (Jan-05-2024): 19,066
World Rank (Jul-30-2023): 19066
Market Cap (Jul-30-2023): 0.17 Billion USD
Headquarters Country: USA
- Rank in Search Criteria: 5592
World Rank (Jan-05-2024): 19,071
World Rank (Jul-30-2023): 19071
Market Cap (Jul-30-2023): 0.17 Billion USD
World Rank (Jan-2022): 19,330
Market Cap (Jan-2022): 0.19 Billion USDHeadquarters Country: USA Annual Revenue in USD: 14 Million USD
Annual Net Income in USD: 14 Million USD
Annual Results for Period ending: May-2021 ending year
- Rank in Search Criteria: 5593
World Rank (Jan-05-2024): 19,071
World Rank (Jul-30-2023): 19071
World Rank (Jan-2022): 19,071
Market Cap (Jan-2022): 0.20 Billion USDHeadquarters Country: USA Annual Revenue in USD: 209 Million USD
Annual Net Income in USD: 31 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5594
World Rank (Jan-05-2024): 19,072
World Rank (Jul-30-2023): 19072
World Rank (Jan-2022): 19,072
Headquarters Country: USA
- Rank in Search Criteria: 5595
World Rank (Jan-05-2024): 19,072
Market Cap (Jan-05-2024): 0.16 Billion USD
World Rank (Jul-30-2023): 16819
Market Cap (Jul-30-2023): 0.25 Billion USD
World Rank (Jan-2022): 18,429
Market Cap (Jan-2022): 0.22 Billion USDAnnual Revenue in USD: 7 Million USD
Annual Net Income in USD: -22 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5596
World Rank (Jan-05-2024): 19,073
Market Cap (Jan-05-2024): 0.16 Billion USD
World Rank (Jul-30-2023): 14630
Market Cap (Jul-30-2023): 0.37 Billion USD
World Rank (Jan-2022): 5,040
Market Cap (Jan-2022): 2.84 Billion USDHeadquarters Country: USA Annual Revenue in USD: 460 Million USD
Annual Net Income in USD: -379 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 3,000
Employee Count as of Date: As on 2021
Company Profile: Invitae Corporation develops Genetics into Mainstream Medicine Solution company. The headquarters is in USA.
- Rank in Search Criteria: 5597
World Rank (Jan-05-2024): 19,075
World Rank (Jul-30-2023): 19075
Market Cap (Jul-30-2023): 0.17 Billion USD
Headquarters Country: USA
- Rank in Search Criteria: 5598
World Rank (Jan-05-2024): 19,081
Market Cap (Jan-05-2024): 0.16 Billion USD
World Rank (Jul-30-2023): 18911
Market Cap (Jul-30-2023): 0.17 Billion USD
Headquarters Country: USA
- Rank in Search Criteria: 5599
World Rank (Jan-05-2024): 19,083
Market Cap (Jan-05-2024): 0.16 Billion USD
World Rank (Jul-30-2023): 20426
Market Cap (Jul-30-2023): 0.13 Billion USD
World Rank (Jan-2022): 25,884
Market Cap (Jan-2022): 0.06 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5600
World Rank (Jan-05-2024): 19,085
Market Cap (Jan-05-2024): 0.16 Billion USD
World Rank (Jul-30-2023): 19561
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 4,108
Market Cap (Jan-2022): 3.74 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -266 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 85
Employee Count as of Date: As on Sep-2021
Company Profile: Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.